102 related articles for article (PubMed ID: 23427142)
21. WNK3 is a putative chloride-sensing kinase.
Pacheco-Alvarez D; Gamba G
Cell Physiol Biochem; 2011; 28(6):1123-34. PubMed ID: 22179001
[TBL] [Abstract][Full Text] [Related]
22. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.
Yang SS; Lo YF; Wu CC; Lin SW; Yeh CJ; Chu P; Sytwu HK; Uchida S; Sasaki S; Lin SH
J Am Soc Nephrol; 2010 Nov; 21(11):1868-77. PubMed ID: 20813865
[TBL] [Abstract][Full Text] [Related]
23. [New perspective on the role of WNK1 and WNK4 in the regulation of NaCl reabsorption and K(+) secretion by the distal nephron].
Rafael C; Chavez-Canales M; Hadchouel J
Med Sci (Paris); 2016 Mar; 32(3):274-80. PubMed ID: 27011246
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of regulation of renal ion transport by WNK kinases.
Huang CL; Yang SS; Lin SH
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
[TBL] [Abstract][Full Text] [Related]
25. Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.
Zeniya M; Sohara E; Kita S; Iwamoto T; Susa K; Mori T; Oi K; Chiga M; Takahashi D; Yang SS; Lin SH; Rai T; Sasaki S; Uchida S
Hypertension; 2013 Nov; 62(5):872-8. PubMed ID: 24019400
[TBL] [Abstract][Full Text] [Related]
26. Renal and brain isoforms of WNK3 have opposite effects on NCCT expression.
Glover M; Zuber AM; O'Shaughnessy KM
J Am Soc Nephrol; 2009 Jun; 20(6):1314-22. PubMed ID: 19470686
[TBL] [Abstract][Full Text] [Related]
27. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
28. Integrated compensatory network is activated in the absence of NCC phosphorylation.
Grimm PR; Lazo-Fernandez Y; Delpire E; Wall SM; Dorsey SG; Weinman EJ; Coleman R; Wade JB; Welling PA
J Clin Invest; 2015 May; 125(5):2136-50. PubMed ID: 25893600
[TBL] [Abstract][Full Text] [Related]
29. Deletion of the WNK3-SPAK kinase complex in mice improves radiographic and clinical outcomes in malignant cerebral edema after ischemic stroke.
Zhao H; Nepomuceno R; Gao X; Foley LM; Wang S; Begum G; Zhu W; Pigott VM; Falgoust LM; Kahle KT; Yang SS; Lin SH; Alper SL; Hitchens TK; Hu S; Zhang Z; Sun D
J Cereb Blood Flow Metab; 2017 Feb; 37(2):550-563. PubMed ID: 26861815
[TBL] [Abstract][Full Text] [Related]
30. With-No-Lysine Kinase 3 (WNK3) stimulates glioma invasion by regulating cell volume.
Haas BR; Cuddapah VA; Watkins S; Rohn KJ; Dy TE; Sontheimer H
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1150-60. PubMed ID: 21813709
[TBL] [Abstract][Full Text] [Related]
31. WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.
Bergaya S; Faure S; Baudrie V; Rio M; Escoubet B; Bonnin P; Henrion D; Loirand G; Achard JM; Jeunemaitre X; Hadchouel J
Hypertension; 2011 Sep; 58(3):439-45. PubMed ID: 21768522
[TBL] [Abstract][Full Text] [Related]
32. Similar effects of all WNK3 variants on SLC12 cotransporters.
Cruz-Rangel S; Melo Z; Vázquez N; Meade P; Bobadilla NA; Pasantes-Morales H; Gamba G; Mercado A
Am J Physiol Cell Physiol; 2011 Sep; 301(3):C601-8. PubMed ID: 21613606
[TBL] [Abstract][Full Text] [Related]
33. WNK3 and WNK4 exhibit opposite sensitivity with respect to cell volume and intracellular chloride concentration.
Pacheco-Alvarez D; Carrillo-Pérez DL; Mercado A; Leyva-Ríos K; Moreno E; Hernández-Mercado E; Castañeda-Bueno M; Vázquez N; Gamba G
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C371-C380. PubMed ID: 32579473
[TBL] [Abstract][Full Text] [Related]
34. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
35. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice.
Kamat NV; Thabet SR; Xiao L; Saleh MA; Kirabo A; Madhur MS; Delpire E; Harrison DG; McDonough AA
Hypertension; 2015 Mar; 65(3):569-76. PubMed ID: 25601932
[TBL] [Abstract][Full Text] [Related]
36. Nephron-Specific Disruption of Nitric Oxide Synthase 3 Causes Hypertension and Impaired Salt Excretion.
Gao Y; Stuart D; Takahishi T; Kohan DE
J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29997131
[TBL] [Abstract][Full Text] [Related]
37. The Role of Epithelial Sodium Channel ENaC and the Apical Cl-/HCO3- Exchanger Pendrin in Compensatory Salt Reabsorption in the Setting of Na-Cl Cotransporter (NCC) Inactivation.
Patel-Chamberlin M; Varasteh Kia M; Xu J; Barone S; Zahedi K; Soleimani M
PLoS One; 2016; 11(3):e0150918. PubMed ID: 26963391
[TBL] [Abstract][Full Text] [Related]
38. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.
Ohta A; Rai T; Yui N; Chiga M; Yang SS; Lin SH; Sohara E; Sasaki S; Uchida S
Hum Mol Genet; 2009 Oct; 18(20):3978-86. PubMed ID: 19633012
[TBL] [Abstract][Full Text] [Related]
39. ASK3 responds to osmotic stress and regulates blood pressure by suppressing WNK1-SPAK/OSR1 signaling in the kidney.
Naguro I; Umeda T; Kobayashi Y; Maruyama J; Hattori K; Shimizu Y; Kataoka K; Kim-Mitsuyama S; Uchida S; Vandewalle A; Noguchi T; Nishitoh H; Matsuzawa A; Takeda K; Ichijo H
Nat Commun; 2012; 3():1285. PubMed ID: 23250415
[TBL] [Abstract][Full Text] [Related]
40. OSR1-sensitive regulation of Na+/H+ exchanger activity in dendritic cells.
Pasham V; Rotte A; Yang W; Zelenak C; Bhandaru M; Föller M; Lang F
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C416-26. PubMed ID: 22648948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
